There were 125 drug shortages by the end of 2023.
As demand for semaglutide injections outstrips supply, unapproved formulations flood the market, raising safety concerns over substitute ingredients.
Health care providers and patients struggle to find critical medications as U.S. officials grapple with solutions.
The number of drug shortages being reported to the government’s mandatory reporting website “has increased dramatically in the last few weeks.”
There were 125 drug shortages by the end of 2023.
As demand for semaglutide injections outstrips supply, unapproved formulations flood the market, raising safety concerns over substitute ingredients.
Health care providers and patients struggle to find critical medications as U.S. officials grapple with solutions.
The number of drug shortages being reported to the government’s mandatory reporting website “has increased dramatically in the last few weeks.”